AzTrials
AzTrials

Muscle StiffnessNCT07822594

Immediate Effects of Two IASTM Tools on Lower-Leg Tissue Stiffness and Ankle Mobility

A study testing Instrument-Assisted Soft Tissue Mobilization Using a Higher-Cost Tool and Instrument-Assisted Soft Tissue Mobilization Using a Lower-Cost Tool in people with Muscle Stiffness, run by University of Primorska at 1 site in Slovenia.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This randomized controlled trial will investigate the immediate effects of instrument-assisted soft tissue mobilization (IASTM) performed with two different commercially available tools on posterior lower-leg tissue stiffness and ankle dorsiflexion range of motion in healthy young adults. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Muscle Stiffness
What is being tested?
Instrument-Assisted Soft Tissue Mobilization Using a Higher-Cost Tool and Instrument-Assisted Soft Tissue Mobilization Using a Lower-Cost Tool
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
45 participants
Where
1 siteSlovenia
Study dates
1 Oct 2026to 15 Jan 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Age 18 to 40 years
  • Healthy volunteer
  • Willing and able to provide written informed consent

Who cannot join

  • Current or previous lower-limb injury
  • Neuromuscular disorder
  • Neurological disorder

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Žiga Kozinc, PhD contact

040161503 ext. +386

ziga.kozinc@s2p.si

Slovenia1 site
  • University of Primorska, Faculty of Health Sciences, Izola

    Izola, Urban Municipality of Koper, 6310

    Ziga Kozinc, PhD, 040161503, ziga.kozinc@fvz.upr.si

Other trials in Slovenia

About this study

Official title: Acute Effects of Instrument-Assisted Soft Tissue Mobilization Using Lower-Cost and Higher-Cost Tools Lower-Leg Tissue Stiffness and Ankle Dorsiflexion Range of Motion in Healthy Adults: A Randomized Controlled Trial

This randomized controlled trial will investigate the immediate effects of instrument-assisted soft tissue mobilization (IASTM) performed with two different commercially available tools on posterior lower-leg tissue stiffness and ankle dorsiflexion range of motion in healthy young adults. Participants will be randomly allocated to one of three parallel groups: IASTM using a higher-cost tool, IASTM using a lower-cost tool, or passive rest without IASTM.

Tissue stiffness at predefined posterior lower-leg sites and ankle dorsiflexion range of motion will be assessed before and immediately after the intervention or equivalent rest period. A single lower limb will be assessed in each participant. Participants receiving IASTM will additionally rate the pleasantness of the intervention and their perceived relaxation after the intervention.

The study will determine whether IASTM produces immediate changes in tissue stiffness and ankle dorsiflexion compared with passive rest and whether these effects differ between the two IASTM tools.

Read the detailed description

Healthy adults aged 18 to 30 years will be randomly allocated to one of three parallel groups: higher-cost IASTM, lower-cost IASTM, or passive control. Only one lower limb will be assessed in each participant; the contralateral limb will not serve as a control.

Before and immediately after the intervention or control period, tissue stiffness will be assessed using MyotonPRO (Myoton AS, Tallinn, Estonia) at four predefined locations: the medial gastrocnemius, lateral gastrocnemius, soleus, and Achilles tendon. Gastrocnemius measurement locations will be identified at one-third of the respective anatomical reference distances described in the protocol. The soleus measurement will be performed medially at one-third of the distance from the medial malleolus toward the medial femoral condyle. The Achilles tendon will be assessed 2 cm proximal to the calcaneus. Two consecutive measurements will be obtained at each site at each assessment, and their mean will be used for analysis.

Ankle dorsiflexion range of motion will be assessed using a digital inclinometer positioned on the lateral aspect of the lower leg during a weight-bearing lunge performed while maintaining the assessed knee extended and the heel in contact with the floor.

Participants in either IASTM group will receive a six-minute standardized treatment of the posterior lower-leg region. The first minute will consist of familiarization with the instrument, desensitization, and application of IASTM cream. This will be followed by five minutes of treatment using long gliding strokes along the direction of the muscle fibers, with the instrument held at approximately a 45-degree angle. Treatment intensity will be adjusted to produce slight pain or moderate discomfort. The treatment protocol will be identical between IASTM groups except for the tool used.

Participants allocated to the control group will rest passively for an equivalent six-minute period without receiving IASTM. Participants receiving IASTM will rate intervention pleasantness and perceived relaxation immediately after treatment using 0-to-10 numerical rating scales.

Being tested
Instrument-Assisted Soft Tissue Mobilization Using a Higher-Cost Tool, Instrument-Assisted Soft Tissue Mobilization Using a Lower-Cost Tool
Keywords
instrument-assisted soft tissue mobilization, soft tissue mobilization, muscle stiffness, ankle dorsiflexion, MyotonPRO, gastrocnemius, soleus, Achilles tendon, range of motion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Instrument-Assisted Soft Tissue Mobilization Using a Higher-Cost ToolProcedure or surgery

    A six-minute standardized IASTM intervention applied to the posterior lower-leg region using a higher-cost IASTM tool. The first minute consists of familiarization, desensitization, and application of IASTM cream, followed by five minutes of long gliding strokes along the direction of the muscle fibers. The instrument is held at approximately 45 degrees and treatment intensity is adjusted to slight pain or moderate discomfort.

  • Instrument-Assisted Soft Tissue Mobilization Using a Lower-Cost ToolProcedure or surgery

    The same six-minute standardized IASTM intervention as in the higher-cost tool condition, performed using a lower-cost IASTM tool. Treatment duration, treated region, stroke direction, instrument angle, and target intensity are standardized between the two IASTM interventions.

Study groups in NCT07822594
Study groupRoleWhat they receive
Higher-Cost IASTMExperimentalParticipants will receive a standardized six-minute IASTM intervention to the posterior lower-leg region using the higher-cost IASTM tool. The first minute will include familiarization, desensitization, and application of IASTM cream, followed by five minutes of standardized treatment.
Receives: Procedure: Instrument-Assisted Soft Tissue Mobilization Using a Higher-Cost Tool
Lower-Cost IASTMActive comparatorParticipants will receive the same standardized six-minute IASTM intervention to the posterior lower-leg region using the lower-cost IASTM tool. Treatment duration, technique, instrument angle, treated region, and intensity will be matched to the higher-cost IASTM group.
Receives: Procedure: Instrument-Assisted Soft Tissue Mobilization Using a Lower-Cost Tool
Passive ControlNo interventionParticipants will rest passively for six minutes without receiving IASTM. Measurements will be performed before and immediately after the rest period using the same procedures as in the intervention groups.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change From Baseline in Medial Gastrocnemius Stiffness

    Tissue stiffness will be measured using MyotonPRO and expressed in N/m. Two consecutive measurements will be obtained at each assessment and averaged.

    Measured: Baseline and immediately after the 6-minute intervention or rest period

  2. Change From Baseline in Lateral Gastrocnemius Stiffness

    Tissue stiffness will be measured using MyotonPRO and expressed in N/m. Two consecutive measurements will be obtained at each assessment and averaged.

    Measured: Baseline and immediately after the 6-minute intervention or rest period

  3. Change From Baseline in Soleus Stiffness

    Tissue stiffness will be measured using MyotonPRO and expressed in N/m. The measurement site will be located medially at one-third of the distance from the medial malleolus toward the medial femoral condyle. Two consecutive measurements will be obtained and averaged.

    Measured: Baseline and immediately after the 6-minute intervention or rest period

  4. Change From Baseline in Achilles Tendon Stiffness

    Achilles tendon stiffness will be measured using MyotonPRO and expressed in N/m at a predefined site 2 cm proximal to the calcaneus. Two consecutive measurements will be obtained and averaged.

    Measured: Baseline and immediately after the 6-minute intervention or rest period

  5. Change From Baseline in Ankle Dorsiflexion Range of Motion

    Ankle dorsiflexion range of motion will be measured in degrees using a digital inclinometer positioned on the lateral aspect of the lower leg during a weight-bearing lunge with the assessed knee maintained in extension and the heel in contact with the floor.

    Measured: Baseline and immediately after the 6-minute intervention or rest period

Secondary outcomes (2)
  1. Perceived Pleasantness of IASTM

    Participants receiving IASTM will rate the pleasantness of the intervention on an 11-point numerical rating scale ranging from 0 to 10, with 0 representing the lowest possible pleasantness and 10 representing the highest possible pleasantness.

    Measured: Immediately after the 6-minute IASTM intervention

  2. Perceived Relaxation After IASTM

    Participants receiving IASTM will rate their perceived relaxation after the intervention on an 11-point numerical rating scale ranging from 0 to 10, with 0 representing the lowest possible relaxation and 10 representing the highest possible relaxation.

    Measured: Immediately after the 6-minute IASTM intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Sep 2026
  2. Study start1 Oct 2026 (estimated)
  3. Primary completion15 Dec 2026 (estimated)
  4. Study completion15 Jan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly allocated to one of three parallel groups: higher-cost IASTM, lower-cost IASTM, or passive rest. One lower limb per participant will be assessed before and immediately after the intervention or equivalent control period.
Masking
None (open label)
Enrolment
45 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07822594
Sponsor's protocol ID
UPFVZ-IASTM-2026
Status last verified
Sep 2026
First submitted
10 Sep 2026
Last updated
17 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified individual participant data underlying the results reported in the publication will be made available upon reasonable request. After publication of scientific manuscript, the data will also be uploaded to a trusted repository (Zenodo.org).

Questions about this trial

What is this clinical trial studying?

A study testing Instrument-Assisted Soft Tissue Mobilization Using a Higher-Cost Tool and Instrument-Assisted Soft Tissue Mobilization Using a Lower-Cost Tool in people with Muscle Stiffness, run by University of Primorska at 1 site in Slovenia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 17 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Slovenia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Žiga Kozinc, PhD (040161503 ext. +386, ziga.kozinc@s2p.si), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change From Baseline in Medial Gastrocnemius Stiffness (time frame: Baseline and immediately after the 6-minute intervention or rest period). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in